These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26389667)

  • 21. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.
    Plenge P; Gether U; Rasmussen SG
    Eur J Pharmacol; 2007 Jul; 567(1-2):1-9. PubMed ID: 17499240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
    du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
    Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A structural model of the human serotonin transporter in an outward-occluded state.
    Hellsberg E; Ecker GF; Stary-Weinzinger A; Forrest LR
    PLoS One; 2019; 14(6):e0217377. PubMed ID: 31251747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine.
    Stahl SM
    CNS Spectr; 2015 Oct; 20(5):455-9. PubMed ID: 26122791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats.
    Mørk A; Montezinho LP; Miller S; Trippodi-Murphy C; Plath N; Li Y; Gulinello M; Sanchez C
    Pharmacol Biochem Behav; 2013 Apr; 105():41-50. PubMed ID: 23380522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological properties of vortioxetine and its pre-clinical consequences].
    David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R
    Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior.
    Eskelund A; Li Y; Budac DP; Müller HK; Gulinello M; Sanchez C; Wegener G
    J Neurochem; 2017 Jul; 142(1):118-131. PubMed ID: 28407315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.
    Pérez PD; Ma Z; Hamilton C; Sánchez C; Mørk A; Pehrson AL; Bundgaard C; Zhang N
    Neuropharmacology; 2018 Jan; 128():379-387. PubMed ID: 29104073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice.
    Li Y; Abdourahman A; Tamm JA; Pehrson AL; Sánchez C; Gulinello M
    Pharmacol Biochem Behav; 2015 Aug; 135():70-82. PubMed ID: 26046533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
    Pehrson AL; Leiser SC; Gulinello M; Dale E; Li Y; Waller JA; Sanchez C
    Eur J Pharmacol; 2015 Apr; 753():19-31. PubMed ID: 25107284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vortioxetine: a new antidepressant to treat depressive episodes].
    Colle R; Corruble E
    Encephale; 2016 Feb; 42(1):48-58. PubMed ID: 26358483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
    Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
    J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures.
    Waller JA; Chen F; Sánchez C
    Neuropharmacology; 2016 Apr; 103():143-54. PubMed ID: 26702943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vortioxetine for the treatment of major depression.
    Dhir A
    Drugs Today (Barc); 2013 Dec; 49(12):781-90. PubMed ID: 24524096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further optimization of novel pyrrole 3-carboxamides for targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.
    Kang SY; Park EJ; Park WK; Kim HJ; Choi G; Jung ME; Seo HJ; Kim MJ; Pae AN; Kim J; Lee J
    Bioorg Med Chem; 2010 Aug; 18(16):6156-69. PubMed ID: 20637635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mannich bases, 5-arylimidazolidine-2,4-dione derivatives with dual 5-HT(1A) receptor and serotonin transporter affinity.
    Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Siwek A; Bojarski AJ; Bednarski M; Wróbel D; Wesołowska A
    Arch Pharm (Weinheim); 2013 Feb; 346(2):98-109. PubMed ID: 23288448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.
    Andersen J; Taboureau O; Hansen KB; Olsen L; Egebjerg J; Strømgaard K; Kristensen AS
    J Biol Chem; 2009 Apr; 284(15):10276-84. PubMed ID: 19213730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of mazindol and analogs to the human serotonin and dopamine transporters.
    Severinsen K; Koldsø H; Thorup KA; Schjøth-Eskesen C; Møller PT; Wiborg O; Jensen HH; Sinning S; Schiøtt B
    Mol Pharmacol; 2014 Feb; 85(2):208-17. PubMed ID: 24214825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for Homology Modeling of Dopamine, Norepinephrine, and Serotonin Transporters.
    Haddad Y; Heger Z; Adam V
    ACS Chem Neurosci; 2016 Nov; 7(11):1607-1613. PubMed ID: 27596073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
    Andersen J; Stuhr-Hansen N; Zachariassen LG; Koldsø H; Schiøtt B; Strømgaard K; Kristensen AS
    Mol Pharmacol; 2014 May; 85(5):703-14. PubMed ID: 24516100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.